Recode has learned that a man who was found dead at a hospital in Fresno, California died of complications from a vaccine for a rare type of skin cancer.

The cause of death is still under investigation, but the cause is believed to be a result of the HPV vaccine.

The patient had a blood clot, and it was found in his left thigh.

The clot was removed and the patient died a few days later.

This type of clot has a 99.99 percent chance of being removed without surgery.

But the vaccine’s makers are known to be cautious about surgery because it could result in more infections in the body.

The coroner’s office in Fresno did not release any additional information about the case.

The man’s family released a statement on Tuesday afternoon saying they were deeply saddened by the news.

“We are deeply saddened to learn of this tragic death, and our hearts go out to his family,” the family wrote in the statement.

“He was a bright and generous person who was deeply committed to his profession.

We are thankful for the incredible support we have received from his loved ones and friends.”

The coroner in Fresno has not released the patient’s name.

A similar case at the hospital in February, when a man in his 30s died of a rare skin cancer, was not related to the vaccine, a person familiar with the case said.

In December, Merck issued a statement saying the company had stopped manufacturing the HPV vaccination in 2018 due to the “unprecedented” number of infections.

In February, Merk announced that it was suspending the use of the vaccine for about three months.

The company said it would be reevaluating the vaccine and re-evaluating vaccine production in the coming months.

Merck said it will resume production of the vaccines once more robust data from clinical trials show there are no serious adverse reactions to the vaccines.

The California Vaccine Injury Compensation Program paid out $5 million in compensation to nearly 500 people who contracted HPV-16, according to Merck.